Sai Capital Ltd (531931)

Sai Capital reported a consolidated net profit of Rs 3.40 Cr for the quarter ended June 30, 2026, primarily driven by 'Other Income' of Rs 6.17 Cr. Revenue from operations remained low at Rs 22.74 Lacs, although it showed a slight increase from Rs 14.75 Lacs in the same quarter last year. On a standalone basis, the company remains non-operational with zero revenue and a net loss of Rs 17.55 Lacs. The company's consolidated performance is heavily dependent on its subsidiaries, including Health Care Energy Foods and Butterfly Ayurveda.

• Consolidated Net Profit stood at Rs 3.40 Cr for Q1 FY27, compared to Rs 3.11 Cr in Q1 FY26.
• Other Income of Rs 6.17 Cr accounted for approximately 96.4% of the total consolidated income of Rs 6.39 Cr.
• Standalone operations reported zero revenue from operations and a net loss of Rs 17.55 Lacs.
• Consolidated Earnings Per Share (EPS) for the quarter was reported at Rs 11.81.
• Total consolidated expenses for the quarter were Rs 1.51 Cr, with depreciation and amortisation accounting for Rs 54.05 Lacs.

Sai Capital reported a consolidated net profit of ₹3.15 Cr for Q1 FY27, a marginal increase from ₹3.05 Cr in the year-ago period. The company's standalone operations continue to generate zero revenue, resulting in a standalone net loss of ₹17.55 Lacs due to administrative and finance costs. Consolidated performance is heavily reliant on 'Other Income', which at ₹6.17 Cr, accounts for approximately 96.4% of the total consolidated income. The consolidated EPS improved to ₹11.81 from ₹10.81 YoY, while the standalone EPS remains negative at -₹0.61.

• Consolidated Net Profit attributable to owners stood at ₹3.15 Cr for the quarter ended June 30, 2026.
• Other Income of ₹6.17 Cr dominates the consolidated total income of ₹6.39 Cr.
• Standalone revenue from operations remained at ₹0.00, consistent with the previous year's quarter.
• Consolidated EPS increased to ₹11.81 compared to ₹10.81 in Q1 FY26.
• Total consolidated expenses decreased slightly to ₹1.51 Cr from ₹1.59 Cr in the corresponding quarter last year.

Sai Capital has scheduled a board meeting for August 13, 2026, to consider and approve un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. The company currently operates with a very small revenue base of ₹1 Cr (TTM) but reported a significantly higher TTM PAT of ₹13 Cr, suggesting substantial non-operating income. The trading window for insiders is set to reopen on August 18, 2026. Investors should note the company's extremely low P/B ratio of 0.1, which indicates the market is valuing the firm at a fraction of its ₹366 Cr net worth.

• Board meeting scheduled for August 13, 2026, to review Q1 FY27 results.
• Trading window for securities will reopen on August 18, 2026.
• Company reported a TTM PAT of ₹13 Cr despite a TTM revenue of only ₹1 Cr.
• Market capitalization stands at ₹42 Cr against a net worth of ₹366 Cr.
• Operating profit margin remains deeply negative at -332.8% for the TTM period.

Sai Capital has released its FY2025-26 Annual Report and scheduled its 31st Annual General Meeting (AGM) for August 25, 2026. The company reported a Net Profit of Rs 12.56 crore for the fiscal year, resulting in an EPS of Rs 43.61, despite a very low revenue base of Rs 1.0 crore. A key agenda item is the re-appointment of Dr. Niraj Kumar Singh as Chairman and Managing Director for a five-year term from 2027 to 2032. The company's net worth of Rs 366 crore significantly exceeds its market capitalization of Rs 41 crore.

• Net Profit for FY26 reported at 1,255.69 (likely Rs 12.56 crore) with an EPS of 43.61
• Proposed re-appointment of Dr. Niraj Kumar Singh as CMD for a 5-year term effective June 25, 2027
• Total administrative and selling expenses decreased to 148.59 (likely Rs 1.49 crore) from 205.00 in FY25
• Net Block of fixed assets stood at 3,165.72 (likely Rs 31.66 crore) as of March 31, 2026
• AGM scheduled for August 25, 2026, to be held via Video Conferencing

Sai Capital Ltd has scheduled its 31st Annual General Meeting (AGM) for August 25, 2026, to be held via video conferencing. The primary agenda includes the re-appointment of Dr. Niraj Kumar Singh as Chairman & Managing Director for a five-year term from June 2027 to June 2032. Notably, the CMD is seeking re-appointment with 'Nil' remuneration, despite the company reporting a TTM PAT of Rs 13 Cr on a very small revenue base of Rs 1 Cr. The board highlights his 43 years of experience as critical for the company's ongoing expansion phase.

• 31st Annual General Meeting scheduled for August 25, 2026, at 12:30 P.M. IST
• Proposed re-appointment of Dr. Niraj Kumar Singh as CMD for a 5-year term starting June 25, 2027
• CMD Dr. Niraj Kumar Singh holds 1,38,600 equity shares, representing a 4.81% stake
• Proposed remuneration for the Managing Director position is Nil
• Dr. Singh brings over 43 years of experience in corporate management and financial services